Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT04597034
Eligibility Criteria:
Inclusion Criteria:
1. Patients aged ≥ 18 years old.
2. A diagnosis of a confirmed, defined by a positive rt-PCR for SARS CoV-2, or suspected COVID-19 disease, with suggestive findings on a chest CT scan.
3. Patients on mechanical ventilation.
4. The presence of an informed consent signed by the next of kin.
5. Patients with KDIGO AKI stage 2: defined by a rise in creatinine 2-2.9 times baseline and/or a urinary output less than 0.5 ml/kg/hr for 12 hours, with failure after a furosemide stress test.
6. The use of vasopressor, any dose.
7. Complete medical history and complete laboratories.
Exclusion Criteria:
1. Chronic kidney disease KDIGO stage 4, 5, or 5D.
2. Next of kin unwilling or patient unwilling to participate.
3. Patients with a life expectancy of fewer than 72 hours according to the attending physician criteria.
4. Patients older than 75 years.
5. Patients with SOFA \> 11.
6. Patients with severe liver failure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04597034
Study Brief:
Protocol Section:
NCT04597034